US Broker Ratings

Quest Diagnostics (DGX) Stock Analysis: Examining Growth Prospects and Analyst Consensus

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, has been capturing investor attention with its..

Cencora, Inc. (COR) Stock Analysis: A Robust Healthcare Player with a 7.85% Upside Potential

Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, stands as a formidable name in the healthcare sector, particularly within the medical distribution industry. With a..

Nuvalent, Inc. (NUVL) Stock Analysis: Assessing the Stability of a Biotech Powerhouse with a $9.79 Billion Market Cap

For investors looking to explore opportunities within the healthcare sector, particularly in biotechnology, Nuvalent, Inc. (NASDAQ: NUVL) presents an intriguing case. With a market capitalization of..

Dr. Reddy’s Laboratories Ltd (RDY): Investor Outlook Amidst a 5.88% Potential Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, continues to capture investor attention with its strategic positioning in the global pharmaceutical..

Illumina, Inc. (ILMN) Stock Analysis: A Healthcare Giant with Strategic Partnerships and Growth Potential

Illumina, Inc. (NASDAQ: ILMN) stands as a titan in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $39.64 billion,..

Avantor, Inc. (AVTR) Stock Analysis: Navigating the Upside in a Competitive Healthcare Sector

Avantor, Inc. (AVTR) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Radnor, Pennsylvania, Avantor has carved..

BeOne Medicines Ltd. (ONC) Stock Analysis: Uncovering a Promising 18.26% Upside in the Biotech Sector

Investors seeking opportunities in the healthcare sector should pay close attention to BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology industry based in Switzerland...

Grifols, S.A. (GRFS) Stock Analysis: Uncovering a 42% Potential Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS) emerges as a compelling prospect for investors seeking exposure to the healthcare sector, particularly in the realm of plasma-derived medicines. Headquartered in..

Novo Nordisk A/S (NVO) Stock Analysis: A Strong Dividend Player with Potential Upside

Novo Nordisk A/S (NYSE: NVO), a Danish healthcare giant, has long been a stalwart in the pharmaceutical industry, particularly in diabetes and obesity care. With a..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a Potential 11% Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the medical devices industry, is currently capturing investor attention with a potential upside of 11.23%..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Navigating a Volatile Market with Innovative TCM Solutions

Regencell Bioscience Holdings L (NASDAQ: RGC), a Hong Kong-based company specializing in Traditional Chinese Medicine (TCM), presents a unique opportunity for investors interested in the healthcare..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring Its 14.66% Upside Potential

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a prominent player in the global pharmaceutical industry, is drawing investor attention with a potential upside of 14.66%, according to..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Biotech Powerhouse with 63% Upside Potential

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a leading player in the biotechnology sector, has been capturing investor attention with its robust pipeline of innovative treatments for genetic..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating Growth Potential Amidst a Robust Market Cap

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a formidable market capitalization..

Alcon Inc. (ALC) Stock Analysis: Exploring a Potential 25% Upside for Healthcare Investors

Alcon Inc. (NYSE: ALC), a Swiss-based leader in the healthcare sector, is drawing significant attention from investors seeking opportunities in the medical instruments and supplies industry...

Henry Schein, Inc. (HSIC) Stock Analysis: Unpacking the 12.14% Potential Upside for Investors

Henry Schein, Inc. (NASDAQ: HSIC), a leading player in the healthcare sector, particularly in the medical distribution industry, offers an intriguing proposition for savvy investors. With..

Vaxcyte, Inc. (PCVX) Investor Outlook: Exploring a Promising 84% Upside Potential in Biotech

As investors navigate the complex landscape of biotechnology stocks, Vaxcyte, Inc. (NASDAQ: PCVX) emerges as a compelling opportunity, marked by a notable market cap of $10.01..

Revvity, Inc. (RVTY) Stock Analysis: Healthcare Innovation with Mixed Investor Sentiments

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, is capturing investor attention with its expansive product offerings and recent rebranding. Formerly known as..

BrightSpring Health Services, Inc. (BTSG) Stock Analysis: A 29.69% Upside Potential in the Healthcare Sector

BrightSpring Health Services, Inc. (NYSE: BTSG) is quickly capturing the attention of investors within the healthcare sector. With a robust market capitalization of $12.04 billion, this..

Halozyme Therapeutics, Inc. (HALO): Investor Outlook on Robust Growth Amidst Valuation Challenges

For investors eyeing opportunities in the healthcare sector, Halozyme Therapeutics, Inc. (NASDAQ: HALO) presents an intriguing mix of robust growth potential and valuation considerations. Based in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds